Lexaliz Adult

Lisdexamfetamine dimesylate, the active ingredient in Lexaliz Adult, is a central nervous system stimulant presented as an oral formulation for oral use. It is indicated for the treatment of attention deficit hyperactivity disorder in adult patients, helping to improve focus and reduce impulsivity. It is marketed within the European Union and follows regulatory guidelines.

GNH USA supplies Lexaliz Adult as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lisdexamfetamine dimesylate is used to manage symptoms within the attention deficit hyperactivity disorder (ADHD) therapeutic area in adults.

- Adult ADHD: improves sustained attention and reduces hyperactive and impulsive behaviors. - Executive function deficits in ADHD: enhances task organization and planning abilities. - Cognitive performance in ADHD: supports better working memory and information processing.

Lisdexamfetamine dimesylate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced food intake leading to weight loss. - Dry mouth: sensation of oral dryness. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, arrhythmia, or sudden increase in blood pressure. - Psychosis: hallucinations or delusional thinking. - Severe hypertension: markedly elevated blood pressure requiring medical attention.

When prescribing lisdexamfetamine dimesylate, clinicians should consider several precautionary measures to ensure safe use.

- Cardiovascular assessment: evaluate blood pressure and heart rate before initiating therapy. - Psychiatric monitoring: watch for emergence of anxiety, mood swings, or psychotic symptoms. - Hypersensitivity screening: avoid use in patients with known allergy to amphetamines. - Substance misuse history: use caution in individuals with prior substance use disorder. - Drug interaction review: assess concomitant medications that may affect catecholamine levels. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Lisdexamfetamine dimesylate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis; avoid concurrent use. - Other central nervous system stimulants: may increase stimulant-related adverse effects. - Serotonergic agents (e.g., SSRIs, SNRIs, tramadol): potential for serotonin syndrome.

Moderate Interactions (Monitor Closely): - Acid‑reducing agents (antacids, proton pump inhibitors): may affect drug absorption, monitor therapeutic response. - Antihypertensive drugs: lisdexamfetamine may diminish blood‑pressure‑lowering effects, requiring dose adjustment.